Numerous studies have demonstrated that abnormal TIMP1 expression is associated with unfavourable prognosis in various tumors, such as gastric cancer [51], cutaneous melanoma [52], papillary thyroid carcinoma [53] and breast cancer [26]. Here, TIMP1 is linked to breast carcinoma.